Ad is loading...
KRYS
Price
$182.29
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
100 days until earnings call
NVCT
Price
$5.10
Change
+$0.20 (+4.08%)
Updated
Nov 22 closing price
108 days until earnings call
Ad is loading...

KRYS vs NVCT

Header iconKRYS vs NVCT Comparison
Open Charts KRYS vs NVCTBanner chart's image
Krystal Biotech
Price$182.29
Change-$0.00 (-0.00%)
Volume$185.18K
CapitalizationN/A
Nuvectis Pharma
Price$5.10
Change+$0.20 (+4.08%)
Volume$170.11K
CapitalizationN/A
KRYS vs NVCT Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KRYS vs. NVCT commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongBuy and NVCT is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (KRYS: $190.40 vs. NVCT: $5.10)
Brand notoriety: KRYS and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 99% vs. NVCT: 85%
Market capitalization -- KRYS: $5.48B vs. NVCT: $98.54M
KRYS [@Biotechnology] is valued at $5.48B. NVCT’s [@Biotechnology] market capitalization is $98.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while NVCT’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 6 bearish.
  • NVCT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both KRYS and NVCT are a bad buy in the short-term.

Price Growth

KRYS (@Biotechnology) experienced а +11.51% price change this week, while NVCT (@Biotechnology) price change was +3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 03, 2025.

NVCT is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.48B) has a higher market cap than NVCT($98.5M). KRYS YTD gains are higher at: 53.474 vs. NVCT (-38.849). KRYS has higher annual earnings (EBITDA): 181M vs. NVCT (-20.26M). KRYS has more cash in the bank: 588M vs. NVCT (17.2M). KRYS has higher revenues than NVCT: KRYS (242M) vs NVCT (0).
KRYSNVCTKRYS / NVCT
Capitalization5.48B98.5M5,559%
EBITDA181M-20.26M-893%
Gain YTD53.474-38.849-138%
P/E Ratio106.97N/A-
Revenue242M0-
Total Cash588M17.2M3,419%
Total Debt7.48MN/A-
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
6
SMR RATING
1..100
79
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSNVCT
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PRFZ44.700.76
+1.73%
Invesco FTSE RAFI US 1500 Small-Mid ETF
QLVD27.190.12
+0.46%
FlexShares Dev Mks ex-US Qual Lw Vol ETF
DBAW34.370.15
+0.44%
Xtrackers MSCI All World exUS Hdg Eq ETF
EEV16.980.02
+0.12%
ProShares UltraShort MSCI Emerging Mkts
SCHJ24.42-0.02
-0.08%
Schwab 1-5 Year Corporate Bond ETF

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+4.45%
CLDX - KRYS
54%
Loosely correlated
+3.05%
BEAM - KRYS
46%
Loosely correlated
+6.23%
ZLDPF - KRYS
45%
Loosely correlated
+3.45%
VCYT - KRYS
44%
Loosely correlated
+1.67%
RXRX - KRYS
43%
Loosely correlated
-0.87%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and KRYS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+4.08%
KRYS - NVCT
33%
Poorly correlated
+4.45%
DARE - NVCT
30%
Poorly correlated
+3.41%
CELU - NVCT
29%
Poorly correlated
-3.16%
PDSB - NVCT
28%
Poorly correlated
-5.00%
EYEN - NVCT
27%
Poorly correlated
+2.38%
More